Steris Extends Former CFO Tokich’s Advisory Role

The latest update is out from Steris ( (STE) ).

On March 31, 2026, Steris plc amended a prior transition agreement with former Chief Financial Officer Michael J. Tokich, extending his post-executive employment as a part-time senior financial advisor from April 1, 2026, through March 31, 2027. During this extended advisory period, Tokich’s annual base salary will be reduced to $60,000, he may receive a discretionary cash bonus, and he will no longer be eligible for company health, dental, life insurance, vacation, disability or other employee benefit plans, while all other terms of the original transition agreement remain in effect.

The most recent analyst rating on (STE) stock is a Hold with a $232.00 price target. To see the full list of analyst forecasts on Steris stock, see the STE Stock Forecast page.

Spark’s Take on STE Stock

According to Spark, TipRanks’ AI Analyst, STE is a Neutral.

The score is primarily driven by solid fundamentals (improving profitability and strong cash generation) and a constructive earnings update with maintained FY2026 guidance. These positives are tempered by weak near-term technicals (trading below major moving averages with negative momentum) and a relatively expensive valuation (P/E ~36.5 with ~1% yield), plus tariff-driven margin pressure highlighted on the call.

To see Spark’s full report on STE stock, click here.

More about Steris

Steris plc operates in the healthcare and life sciences industry, providing sterilization, infection prevention and procedural products and services to hospitals, pharmaceutical companies and other medical facilities. The company focuses on supporting clinical and research environments with equipment, consumables and service solutions designed to ensure safety, compliance and operational efficiency.

Average Trading Volume: 837,894

Technical Sentiment Signal: Hold

Current Market Cap: $21.45B

For an in-depth examination of STE stock, go to TipRanks’ Overview page.